Brown, Lisle/Cummings’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Brown, Lisle/Cummings's GILD Position: Q1 2026 in Review
Brown, Lisle/Cummings held its Gilead Sciences (GILD) position steady in Q1 2026 at 1,349 shares worth $188K. The position accounts for 0.05% of the portfolio, ranked #220.
Brown, Lisle/Cummings first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. The position peaked at $558K in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Brown, Lisle/Cummings held 1,349 shares of Gilead Sciences worth $188K as of Q1 2026.
- Brown, Lisle/Cummings left its Gilead Sciences share count unchanged in Q1 2026.
- Gilead Sciences made up 0.05% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #220 holding.
- Brown, Lisle/Cummings first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
- Brown, Lisle/Cummings's Gilead Sciences position peaked at $558K in Q4 2022.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.